Literature DB >> 4324024

Australia antigen: a genetic basis for chronic liver disease and hepatoma?

A I Sutnick, W T London, B S Blumberg.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 4324024

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

Review 1.  Mendelian inheritance or transmissible agent? The lesson Kuru and the Australia antigen.

Authors:  P S Harper
Journal:  J Med Genet       Date:  1977-12       Impact factor: 6.318

Review 2.  [Carcinofetal antigens. I. alpha-fetoprotein (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1975-02-15

Review 3.  Molecular mechanisms of the preventable causes of cancer in the United States.

Authors:  Erica A Golemis; Paul Scheet; Tim N Beck; Eward M Scolnick; David J Hunter; Ernest Hawk; Nancy Hopkins
Journal:  Genes Dev       Date:  2018-06-26       Impact factor: 11.361

Review 4.  Current transfusion therapy.

Authors:  E Hinkes; R O Steffen
Journal:  Calif Med       Date:  1973-05

Review 5.  Hepatitis in the individual.

Authors:  C M Leevy; C H Tamburro; M F Sorrell; R Stone
Journal:  Can Med Assoc J       Date:  1972-02-26       Impact factor: 8.262

6.  Hepatocarcinoma and myocardial fibrosis in an 8 and three-fourths year-old renal transplant recipient.

Authors:  G S Arbus; R H Hung
Journal:  Can Med Assoc J       Date:  1972-09-09       Impact factor: 8.262

7.  Hepatocellular carcinoma, positive Australia (hepatitis-associated) antigen and sarcoidosis.

Authors:  R M Myerson; A Soroush; P V Skerrett
Journal:  Am J Dig Dis       Date:  1971-09

Review 8.  Hepatoma--nature's model tumor. A review.

Authors:  F F Becker
Journal:  Am J Pathol       Date:  1974-01       Impact factor: 4.307

9.  Familial clustering of hepatitis B antigen and liver diseases in families with a high incidence of viral hepatitis.

Authors:  F Piccinino; G Manzillo; E Sagnelli; G Balestrieri; G Maio
Journal:  Infection       Date:  1975       Impact factor: 3.553
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.